AU6926500A - Fatty acid synthase inhibitors - Google Patents

Fatty acid synthase inhibitors

Info

Publication number
AU6926500A
AU6926500A AU69265/00A AU6926500A AU6926500A AU 6926500 A AU6926500 A AU 6926500A AU 69265/00 A AU69265/00 A AU 69265/00A AU 6926500 A AU6926500 A AU 6926500A AU 6926500 A AU6926500 A AU 6926500A
Authority
AU
Australia
Prior art keywords
fatty acid
acid synthase
synthase inhibitors
inhibitors
fatty
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU69265/00A
Other languages
English (en)
Inventor
Siegfried B. Christensen Iv
Robert A Daines
Jack D. Leber
Joseph Weinstock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU6926500A publication Critical patent/AU6926500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU69265/00A 1999-08-23 2000-08-23 Fatty acid synthase inhibitors Abandoned AU6926500A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15027699P 1999-08-23 1999-08-23
US60150276 1999-08-23
PCT/US2000/023073 WO2001014362A1 (fr) 1999-08-23 2000-08-23 Inhibiteurs de synthase d'acide gras

Publications (1)

Publication Number Publication Date
AU6926500A true AU6926500A (en) 2001-03-19

Family

ID=22533807

Family Applications (1)

Application Number Title Priority Date Filing Date
AU69265/00A Abandoned AU6926500A (en) 1999-08-23 2000-08-23 Fatty acid synthase inhibitors

Country Status (4)

Country Link
EP (1) EP1206463A4 (fr)
JP (1) JP2003507467A (fr)
AU (1) AU6926500A (fr)
WO (1) WO2001014362A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001278709A1 (en) 2000-08-11 2002-02-25 Kaken Pharmaceutical Co..Ltd. 2,3-diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage
KR102194745B1 (ko) 2013-03-13 2020-12-24 포르마 세라퓨틱스 인크. Ｆａｓｎ 억제용 신규 화합물 및 조성물
CN103539668B (zh) * 2013-10-22 2015-07-01 山西省化工研究所（有限公司） 合成对苯二亚甲基双丙二酸二乙酯紫外线吸收剂的工艺
TWI767148B (zh) 2018-10-10 2022-06-11 美商弗瑪治療公司 抑制脂肪酸合成酶(fasn)
WO2020092395A1 (fr) 2018-10-29 2020-05-07 Forma Therapeutics, Inc. Formes solides de (4-(2-fluoro-4-(1-méthyl-1h-benzo[d]imidazol-5-yl)benzoyl)pipérazin-1-yl)(1-hydroxycyclopropyl)méthanone

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3528977A (en) * 1966-12-14 1970-09-15 Colgate Palmolive Co Substituted t-aminophenylalanines
FR2137211B1 (fr) * 1971-05-17 1974-08-02 Bouchara Emile
IT1177966B (it) * 1984-08-14 1987-09-03 Medosan Ind Biochimi Derivati amidici dell'acido 2-(p-aminobenzil)butirrico e relativi e-steri provvisti di attivita' ipolipidemizzante
JPH04120040A (ja) * 1990-09-11 1992-04-21 Sumitomo Chem Co Ltd 光学活性なフェノール誘導体およびその製造法
JPH04124158A (ja) * 1990-09-12 1992-04-24 Sumitomo Chem Co Ltd 光学活性なフェノール誘導体およびその製造法
US5614551A (en) * 1994-01-24 1997-03-25 The Johns Hopkins University Inhibitors of fatty acid synthesis as antimicrobial agents

Also Published As

Publication number Publication date
EP1206463A4 (fr) 2003-01-29
JP2003507467A (ja) 2003-02-25
EP1206463A1 (fr) 2002-05-22
WO2001014362A1 (fr) 2001-03-01

Similar Documents

Publication Publication Date Title
AU2001270200A1 (en) Fatty acid synthase inhibitors
AU5634999A (en) Hydroxamic acid derivatives as proteinase inhibitors
AU2001236052A1 (en) Urease inhibitors
AU2001280167A1 (en) Novel propenohydroxamic acid derivatives
AU2001281059A1 (en) Fatty acid synthase inhibitors
AU7961300A (en) Kainic acid neurocytotoxicity inhibitors
IL148324A0 (en) Fatty acid synthase inhibitors
AUPP982399A0 (en) Mmp inhibitor
AU7126900A (en) Enzyme inhibitors
AU2001271531A1 (en) Fatty acid synthase inhibitors
AU3235100A (en) Prothease inhibitors
AU3761400A (en) Amino-thio-acrylonitriles as mek inhibitors
GB9924522D0 (en) Enzyme inhibitors
AU2002224550A1 (en) Corrosion inhibitors
AU6925500A (en) Fatty acid synthase inhibitors
AU1303201A (en) Alkoxyiminoalkanoic acid derivatives
AU2001274940A1 (en) Fatty acid synthase inhibitors
AU2002243439A1 (en) Fatty acid synthase inhibitors
AU6926500A (en) Fatty acid synthase inhibitors
AU2001271718A1 (en) Fatty acid synthase inhibitors
AU7127000A (en) Enzyme inhibitors
AU2001284705A1 (en) Fatty acid synthase inhibitors
AU2001291160A1 (en) Fatty acid synthase inhibitors
AU7608100A (en) 1-cyclohexene-1-carboxylic acid and 1-cyclohexene-1-carboxylates as neuraminidase inhibitors
AU7887100A (en) Corrosion inhibitor

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase